The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy

Brain

Volumn 121, Issue 3, 1998, Pages 421-428

  Van Den Berg, L H ^a,b   Franssen, H ^a   Wokke, J H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Intravenous immunoglobulins; Long term treatment; Multifocal motor neuropathy

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MALE; MOTOR NEUROPATHY; MUSCLE STRENGTH; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TIME; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; ELECTROPHYSIOLOGY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUSCLES; NEURAL CONDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031906810     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.3.421     Document Type: Article

References (35)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. [Review]. Neurology 1991; 41: 617-8.
2. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985; 8: 528-39.
3. Azulay JP, Blin O, Pouget J, Boucraut J, Bille-Turc F, Carles G, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994; 44: 429-32.
4. Azulay JP, Rihet P, Pouget J, Cador F, Blin O, Boucraut J, et al. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 1997; 62: 391-4.
5. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA Jr. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987; 83: 1-9.
6. Biessels GJ, Franssen H, van den Berg LH, Gipson A, Kappelle LJ, Venables GS, et al. Multifocal motor neuropathy. [Review]. J Neurol 1997; 244: 143-52.
7. Bouche P, Moulonguet A, Younes-Chennoufi AB, Adams D, Baumann N, Meininger V, et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995; 59: 38-44.
8. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, et al. Multifocal motor neuropathy: response to human immune globulin [see comments]. Ann Neurol 1993; 33: 237-42. Comment in: Ann Neurol 1993; 34: 750-1.
9. Comi G, Amadio S, Galardi G, Fazio R, Nemni R. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1994; 57 Suppl: 35-7.
10. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994; 57: 778-83.
11. Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 1994; 44: 967-8.
12. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991; 30: 397-401.
13. Franssen H, Wieneke GH. Nerve conduction and temperature: necessary warming time. Muscle Nerve 1994; 17: 336-44.
14. Franssen H, Vermeulen M, Jennekens FG. Chronic inflammatory neuropathies. In: Emery, AEH, editor. Diagnostic criteria for neuromuscular disorders. 2nd ed. London: Royal Society of Medicine Press; 1997. p. 53-9.
15. Kornberg AJ, Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. [Review]. Ann Neurol 1995; 37 (Suppl 1): S43-S50.
16. Leger JM. Multifocal motor neuropathy and chronic inflammatory demyelinating polyradiculoneuropathy. [Review]. Curr Opin Neurol 1995; 8: 359-63.
17. Leger JM, Younes-Chennoufi AB, Chassande B, Davila G, Bouche P, Baumann N, et al. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. [Review]. J Neurol Neurosurg Psychiatry 1994; 57; 46-9.
18. Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992; 70: 2703-12.
19. Meucci N, Nobile-Orazio E, Barbieri S, Cappellari A, Scarlato G. Long-term follow-up of multifocal motor neuropathy patients treated with intravenous immunoglobulins and oral cyclophosphamide [abstract]. Neurology 1996; 46 (2 Suppl): A235.
20. Nobile-Orazio E. Multifocal motor neuropathy [editorial]. [Review]. J Neurol Neurosurg Psychiatry 1996; 60: 599-603.
21. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy [see comments]. Neurology 1993; 43: 537-14. Comment in: Neurology 1993; 43: 2727-8.
22. Parry GJ, Sumner AJ. Multifocal motor neuropathy. [Review]. Neurol Clin 1992; 10: 671-84.
23. Pederson-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988; 318: 1028-32.
24. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, et al. A treatable multifocal motor neuropathy with antibodies to the GM1 ganglioside. Ann Neurol 1988; 24: 73-8.
25. Pestronk A, Lopate A, Kornberg AJ, Elliott JL, Blume G, Yee WC, et al. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies. Neurology 1994; 44: 2027-31.
26. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol 1990; 28: 146-56.
27. Van den Berg LH, Marrink J, de Jager AE, de Jong HJ, van Imhoff GW, Latov N, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1992; 55: 8-11.
28. Van den Berg LH, Franssen H, Wokke JH. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology 1995a; 45: 987-8.
29. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatry 1995b; 59: 248-52.
30. Van den Berg LH, Lokhorst H, Wokke JHJ. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997; 48: 1135.
31. Van der Ploeg RJ, Fidler V, Oosterhuis HJ. Hand-held myometry: reference values [see comments]. J Neurol Neurosurg Psychiatry 1991; 54: 244-7. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 982.
32. Van Doom PA, Vermeulen M, Brand A, Mulder PG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 1991; 48: 217-20.
33. Van Es HW, Van den Berg LH, Franssen H, Witkamp TD, Ramos LM, Notermans NC, et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997; 48: 1218-24.
34. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-7.
35. Willison HJ. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? [editorial]. J Neurol Neurosurg Psychiatry 1994; 57: 1303-7.